Inhibition by N-(4-hydroxyphenyl) retinamide of exogenous and endogenous liver carcinogenesis in rats

被引:0
|
作者
Nakae, D
Tamura, K
Akai, H
Kobayashi, Y
Horiguchi, K
Denda, A
Konishi, Y
机构
来源
RECENT ADVANCES IN GASTROENTEROLOGICAL CARCINOGENESIS I | 1996年
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The effects of N-(4-hydroxyphenyl)retinamide (4-HPR) on diethylnitrosamine (DEN)-initiated exogenous and a choline-deficient, L-amino acid-defined (CDAA) diet-associated endogenous rat liver carcinogenesis were studied. In the exogenous model, male Fischer 344 rats, 6 weeks old, were given 200 mg/kg body weight of DEN, partially hepatectomized on Week 3, and administered 4-HPR at doses of 0, 0.04, 0.08 and 0.16% between Weeks 2 and 8. In the endogenous model, rats were fed the CDAA diet containing 4-HPR for 12 weeks. 4-HPR inhibited development of glutathione S-transferase placental form (GST-P)-positive foci in both models, more prominent in the latter case. 4-HPR also inhibited the induction of hepatocyte necrosis and connective tissue increase caused by the CDAA diet. It is thus indicated for 4-HPR to exert chemopreventive effects against exogenous and endogenous rat liver carcinogenesis.
引用
收藏
页码:1163 / 1166
页数:4
相关论文
共 50 条
  • [31] N-(4-HYDROXYPHENYL)RETINAMIDE - INTERACTIONS WITH RETINOID-BINDING PROTEINS/RECEPTORS
    SANI, BP
    SHEALY, YF
    HILL, DL
    CARCINOGENESIS, 1995, 16 (10) : 2531 - 2534
  • [32] Effects of chronic administration of N-(4-hydroxyphenyl)retinamide (4-HPR) in rats on vitamin A metabolism in the eye
    Lewis, KC
    Zech, LA
    Phang, JM
    EUROPEAN JOURNAL OF CANCER, 1996, 32A (10) : 1803 - 1808
  • [33] PREVENTION OF PRIMARY PROSTATE-CANCER IN LOBUND-WISTAR RATS BY N-(4-HYDROXYPHENYL)RETINAMIDE
    POLLARD, M
    LUCKERT, PH
    SPORN, MB
    CANCER RESEARCH, 1991, 51 (13) : 3610 - 3611
  • [34] N-(4-HYDROXYPHENYL)RETINAMIDE (FENRETINIDE) INDUCES RETINOL-BINDING PROTEIN SECRETION FROM LIVER AND ACCUMULATION IN THE KIDNEYS IN RATS
    SCHAFFER, EM
    RITTER, SJ
    SMITH, JE
    JOURNAL OF NUTRITION, 1993, 123 (09): : 1497 - 1503
  • [35] Antagonistic effects of sodium butyrate and N-(4-hydroxyphenyl)retinamide on prostate cancer
    Kuefer, R.
    Genze, F.
    Zugmaier, W.
    Rinnab, L.
    Hautmann, R. E.
    Buechele, B.
    EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 277 - 277
  • [36] Cytotoxic responses to N-(4-hydroxyphenyl)retinamide in human pancreatic cancer cells
    Maria C. Messner
    Myles C. Cabot
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 477 - 487
  • [37] Antagonistic effects of sodium butyrate and N-(4-hydroxyphenyl)-retinamide on prostate cancer
    Kuefer, Rainer
    Genze, Felicitas
    Zugmaier, Waltraud
    Hautmann, Richard E.
    Rinnab, Ludwig
    Gschwendz, Juergen E.
    Angelmeier, Marina
    Estrada, Aidee
    Buechele, Berthold
    NEOPLASIA, 2007, 9 (03): : 246 - 253
  • [38] N-(4-HYDROXYPHENYL) RETINAMIDE IS ANTICLASTOGENIC IN HUMAN LYMPHOBLASTOID CELL-LINES
    TRIZNA, Z
    BENNER, SE
    SHIRLEY, L
    FURLONG, C
    HONG, WK
    ANTICANCER RESEARCH, 1993, 13 (02) : 355 - 356
  • [39] An unhydrolyzable analogue of N-(4-hydroxyphenyl)retinamide:: Synthesis and preliminary biological studies
    Weiss, KL
    Alshafie, G
    Chapman, JS
    Mershon, SM
    Abou-Issa, H
    Clagett-Dame, M
    Curley, RW
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (12) : 1583 - 1586
  • [40] Intravesical N-(4-hydroxyphenyl) retinamide and Adriamycin induces apoptosis in bladder cancer
    Qian, Lixin
    Ding, Hong
    Zhou, Jianwei
    Wang, Xinru
    Shao, Pengfei
    Wu, Shen
    Yang, Jie
    Feugang, Jean M.
    Zou, Changping
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2006, 11 : 2045 - 2051